Randomized controlled trial of patch angioplasty for carotid endarterectomy. The Joint Vascular Research Group

C J Ranaboldo1, A A Barros D'Sa, P R Bell

  • 1Department of Vascular Surgery, Royal South Hampshire Hospital, Southampton, UK.

Insights

Patch angioplasty in carotid endarterectomy reduces immediate complications and significantly lowers long-term restenosis and occlusion rates. This surgical technique improves patient outcomes and vessel patency one year post-operation.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Research

Background:

  • Carotid endarterectomy is a procedure to remove plaque from carotid arteries.
  • Postoperative complications and restenosis remain concerns after carotid endarterectomy.

Purpose of the Study:

  • To evaluate the efficacy of patch angioplasty in reducing complications and restenosis after carotid endarterectomy.

Main Methods:

  • A randomized controlled trial involving 213 patient episodes.
  • Patients were allocated to either patch angioplasty or standard closure.
  • Follow-up included duplex scanning at 1 year.

Main Results:

  • Patch angioplasty was associated with fewer immediate postoperative complications, including hemorrhage and neurological events.
  • Significantly lower rates of vessel restenosis and occlusion were observed in the patch angioplasty group at 1 year (P < 0.01).
  • The overall 30-day stroke or mortality rate was 2.8%.

Conclusions:

  • Patch angioplasty is effective in reducing immediate postoperative complications following carotid endarterectomy.
  • Patch angioplasty significantly lowers the rate of vessel restenosis and occlusion at one year.
  • The use of patch angioplasty improves long-term outcomes for patients undergoing carotid endarterectomy.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...